256 related articles for article (PubMed ID: 2211198)
1. Prophylactic irradiation of the para-aortic lymph node chain in stage IIB and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 7920.
Rotman M; Choi K; Guse C; Marcial V; Hornback N; John M
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):513-21. PubMed ID: 2211198
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study.
Chatani M; Matayoshi Y; Masaki N; Narumi Y; Teshima T; Inoue T
Strahlenther Onkol; 1995 Nov; 171(11):655-60. PubMed ID: 7502230
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
[TBL] [Abstract][Full Text] [Related]
5. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
6. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
7. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
9. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
[TBL] [Abstract][Full Text] [Related]
10. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
13. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.
Small W; Winter K; Levenback C; Iyer R; Gaffney D; Asbell S; Erickson B; Jhingran A; Greven K
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1081-7. PubMed ID: 17398031
[TBL] [Abstract][Full Text] [Related]
14. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone.
Mendenhall WM; Thar TL; Bova FJ; Marcus RB; Morgan LS; Million RR
Cancer; 1984 Jun; 53(12):2649-54. PubMed ID: 6722723
[TBL] [Abstract][Full Text] [Related]
16. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
Perez CA; Grigsby PW; Camel HM; Galakatos AE; Mutch D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):703-16. PubMed ID: 7860381
[TBL] [Abstract][Full Text] [Related]
17. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R
Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547
[TBL] [Abstract][Full Text] [Related]
20. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]